Stockscreener 앱 받기
95.77
1.12%
1.0584
전일 마감가:
$94.71
열려 있는:
$94.91
하루 거래량:
458.19K
Relative Volume:
0.32
시가총액:
$18.96B
수익:
$7.83B
순이익/손실:
$825.20M
주가수익비율:
23.32
EPS:
4.1067
순현금흐름:
$1.05B
1주 성능:
-3.10%
1개월 성능:
-7.09%
6개월 성능:
-6.43%
1년 성능:
-7.47%
1일 변동 폭
$94.55
$96.33
1주일 범위
$94.55
$99.86
52주 변동 폭
$89.24
$114.72
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.73 | 18.76B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
132.28 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.61 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.00 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.91 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.24 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Zimmer Biomet Earnings Preview: What to Expect - inkl
BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $12 - GuruFocus
Candlestick signals on Zimmer Biomet Holdings Inc. stock todayEarnings Beat & Free Low Drawdown Momentum Trade Ideas - newser.com
Johnson Investment Counsel Inc. Sells 22,675 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Will Zimmer Biomet Holdings Inc. see short term momentumMarket Movers & Safe Entry Point Alerts - newser.com
Price momentum metrics for Zimmer Biomet Holdings Inc. explainedLayoff News & Community Consensus Stock Picks - newser.com
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain institutional flowsChart Signals & Reliable Price Action Trade Plans - newser.com
Matrix Asset Advisors Inc. NY Lowers Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Q3 Earnings To Highlight Innovation And GrowthWhy I Think It's A Buy - Seeking Alpha
Analyzing drawdowns of Zimmer Biomet Holdings Inc. with statistical tools2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Costello Asset Management INC Sells 6,560 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Stock Position Raised by Callan Family Office LLC - MarketBeat
Zimmer Biomet Earnings Preview: What To Expect - Barchart.com
RBC Trims Price Target on Zimmer Biomet Holdings to $111 From $115, Keeps Outperform Rating - MarketScreener
Custom watchlist performance reports with Zimmer Biomet Holdings Inc.Market Activity Summary & Community Consensus Stock Picks - newser.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Truist Financial Corp - MarketBeat
Zimmer Biomet launches foot, ankle trauma systems - MassDevice
Tag Archives: foot and ankle trauma - InkFreeNews.com
Zimmer Biomet Launches Foot, Ankle Solutions For Complex Trauma Cases - InkFreeNews.com
Market reaction to Zimmer Biomet Holdings Inc.’s recent newsDollar Strength & Low Drawdown Momentum Ideas - newser.com
Is Zimmer Biomet Holdings Inc. stock attractive after correctionAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Is Zimmer Biomet Holdings Inc ZIM a good long term investmentStock Price Divergence & Small Investment Portfolio Tips - earlytimes.in
Identifying reversal signals in Zimmer Biomet Holdings Inc.Weekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Janney Montgomery Scott LLC Acquires 9,482 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet's (ZBH) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Zimmer Biomet Completes Acquisition Of Orthopedic Robotics Company - InkFreeNews.com
Zimmer Biomet closes acquisition of Monogram Technologies - MSN
Zimmer Biomet launches new solutions for complex foot and ankle trauma - Investing.com Canada
Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions - Nasdaq
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases - PR Newswire
Robeco Institutional Asset Management B.V. Sells 10,504 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Secured Retirement Advisors LLC Invests $413,000 in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies - MarketScreener
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio - MassDevice
Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Tech - GuruFocus
Zimmer Biomet Acquires Monogram Orthopaedics on October 7, 2025 - TipRanks
Zimmer Biomet Acquires Monogram Technologies to Enhance Robotics - TipRanks
Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc.. - MarketScreener
Evercore ISI Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00 - MarketBeat
What analysts say about Zimmer Biomet Holdings Inc ZIM stockPrice-to-Earnings Ratio Insights & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Oct. 7Zimmer Biomet acquires AI-robotics orthopedic company Monogram Technologies - Fort Wayne Business Weekly
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M - GuruFocus
Evercore ISI Adjusts Zimmer Biomet Price Target to $104 From $106, Maintains In Line Rating - MarketScreener
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies - GuruFocus
Does Japan’s Approval of Iodine Hip Implants Alter the Bull Case for Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet Completes Acquisition of Monogram Technologies - WV News
Zimmer Biomet completes acquisition of Monogram Technologies - Investing.com
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Analysts - MarketBeat
Will Japan’s Approval of Iodine Hip Implants Redefine Zimmer Biomet Holdings' (ZBH) Infection Prevention Narrative? - Sahm
How Zimmer Biomet Holdings Inc. stock valuation compares with sectorJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
0.88%
자본화:
|
볼륨(24시간):